缩写名/全名 |
DRUG DELIV
DRUG DELIVERY |
||||||||||||||||
ISSN号 | 1071-7544 | ||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||
影响因子 | 2015:4.843, 2016:6.402, 2017:3.095, 2018:3.829, 2019:4.902, | ||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||
年文章数 | 125 | ||||||||||||||||
出版年份 | 1993 | ||||||||||||||||
是否OA | Yes | ||||||||||||||||
审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||
录用比例 | 较易 | ||||||||||||||||
投稿链接 | https://mc.manuscriptcentral.com/udrd | ||||||||||||||||
投稿官网 | http://informahealthcare.com/drd | ||||||||||||||||
h-index | 52 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1071-7544%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Author: Lei M1, Ma G2,3, Sha S1, Wang X2, Feng H2, Zhu Y2, Du X2. Journal: Drug Deliv. 2019 Dec;26(1):262-272. doi: 10.1080/10717544.2019.1580797. PubMed DOI |
2. | Preparation and drug delivery of dextran-drug complex. Author: Huang S1, Huang G1. Journal: Drug Deliv. 2019 Dec;26(1):252-261. doi: 10.1080/10717544.2019.1580322. PubMed DOI |
3. | Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Author: Zhou J1,2, Sun M3, Jin S4, Fan L5, Zhu W2, Sui X2, Cao L6, Yang C1, Han C2. Journal: Drug Deliv. 2019 Dec;26(1):281-289. doi: 10.1080/10717544.2019.1580799. PubMed DOI |
4. | Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig. Author: Tao Y1, Yang F2, Meng K2, Chen D1, Yang Y2, Zhou K2, Luo W2, Qu W2, Pan Y2, Yuan Z1,2, Xie S2. Journal: Drug Deliv. 2019 Dec;26(1):273-280. doi: 10.1080/10717544.2019.1580798. PubMed DOI |
5. | pH and reduction dual-responsive micelles based on novel polyurethanes with detachable poly(2-ethyl-2-oxazoline) shell for controlled release of doxorubicin. Author: Bu L1, Zhang H1, Xu K1, Du B1, Zhu C2, Li Y1. Journal: Drug Deliv. 2019 Dec;26(1):300-308. doi: 10.1080/10717544.2019.1580323. PubMed DOI |
6. | Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Author: Wu Q1, Liu D2, Zhang X1, Wang D1, DongYe M1, Chen W1, Lin D1, Zhu F2, Chen W1, Lin H1. Journal: Drug Deliv. 2019 Dec;26(1):290-299. doi: 10.1080/10717544.2019.1582728. PubMed DOI |
7. | Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study. Author: Ren L1,2, Wang J1, Chen G1. Journal: Drug Deliv. 2019 Dec;26(1):309-317. doi: 10.1080/10717544.2019.1568623. PubMed DOI |
8. | Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Author: Zhang R1, Qin X1, Kong F2, Chen P2, Pan G3. Journal: Drug Deliv. 2019 Dec;26(1):328-342. doi: 10.1080/10717544.2019.1582730. PubMed DOI |
9. | Recent progress in LyP-1-based strategies for targeted imaging and therapy. Author: Song N1, Zhao L1, Zhu M2, Zhao J1. Journal: Drug Deliv. 2019 Dec;26(1):363-375. doi: 10.1080/10717544.2019.1587047. PubMed DOI |
10. | Transdermal metformin hydrochloride-loaded cubic phases: in silico formulation optimization, preparation, properties, and application for local treatment of melanoma. Author: Yu X1,2, Zhou W2, Wang H2, Lu S1, Jin Y2, Fu J2. Journal: Drug Deliv. 2019 Dec;26(1):376-383. doi: 10.1080/10717544.2019.1587046. PubMed DOI |
|
|